Salomon Azoulay sold $20K of MBX Biosciences stock
By AlphaYouPublished Form 4
Azoulay Salomon
Reporting filer
Salomon Azoulay reported selling 373 shares of MBX Biosciences, Inc. for about $20K ($53.96 a share on average). Form 4 filed Nov 5, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Azoulay Salomon | 2026-11-04 | S | Sale | 373 | 53.96 | 14,026 | 1 day | Filed terms
|
Common Stock
- Owner
- Azoulay Salomon
- Date
- 2026-11-04
- Code
- S
- Action
- Sale
- Quantity
- 373
- Price
- 53.96
- Following holdings
- 14,026
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- transaction Shares: 373
- id: F1
- transaction Price Per Share: 53.96
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 14026
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Azoulay Salomon: Chief Medical Officer.
- F1: The sales reported on this Form 4 represent shares of common stock sold by the Reporting Person to cover tax obligations in connection with the vesting of restricted stock units, pursuant to a mandatory sell-to-cover agreement between the Reporting Person and the Company.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold on an aggregate basis for all Company participants, at prices ranging from $51.78 to $56.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.